{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:46:10Z","timestamp":1791413170432,"version":"4.3.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/sj.leu.2404958","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T07:41:54Z","timestamp":1190878914000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody"],"prefix":"10.1038","volume":"22","author":[{"given":"C","family":"Callens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I C","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Lepelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Renand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dussiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ghez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R C","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,27]]},"reference":[{"key":"BF2404958_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/ijc.2910290606","volume":"29","author":"Y Hinuma","year":"1982","unstructured":"Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982; 29: 631\u2013635.","journal-title":"Int J Cancer"},{"key":"BF2404958_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407\u2013410.","journal-title":"Lancet"},{"key":"BF2404958_CR3","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL . Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058\u20136068.","journal-title":"Oncogene"},{"key":"BF2404958_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1447-0756.2004.00227.x","volume":"30","author":"Y Ando","year":"2004","unstructured":"Ando Y, Ekuni Y, Matsumoto Y, Nakano S, Saito K, Kakimoto K et al. Long-term serological outcome of infants who received frozen-thawed milk from human T-lymphotropic virus type-I positive mothers. J Obstet Gynaecol Res 2004; 30: 436\u2013438.","journal-title":"J Obstet Gynaecol Res"},{"key":"BF2404958_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol 1991; 79: 428\u2013437.","journal-title":"Br J Haematol"},{"key":"BF2404958_CR6","first-page":"147","volume-title":"Retrovirus Biology and Human Disease","author":"K Takatsuki","year":"1990","unstructured":"Takatsuki K . Adult T-cell leukemia\/lymphoma. In: Gallo RC, Wong-Staal F (eds). Retrovirus Biology and Human Disease. Marcel Dekker: New York, 1990, pp 147\u2013159."},{"key":"BF2404958_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.20144","volume":"110","author":"A Okayama","year":"2004","unstructured":"Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y et al. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia\/lymphoma in asymptomatic carriers. Int J Cancer 2004; 110: 621\u2013625.","journal-title":"Int J Cancer"},{"key":"BF2404958_CR8","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","volume":"86","author":"G Franchini","year":"1995","unstructured":"Franchini G . Molecular mechanisms of human T-cell leukemia\/lymphotropic virus type I infection. Blood 1995; 86: 3619\u20133639.","journal-title":"Blood"},{"key":"BF2404958_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida M . Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475\u2013496.","journal-title":"Annu Rev Immunol"},{"issue":"17 Suppl","key":"BF2404958_CR10","first-page":"5697S","volume":"50","author":"K Maruyama","year":"1990","unstructured":"Maruyama K, Fukushima T, Kawamura K, Mochizuki S . Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I. Cancer Res 1990; 50 (17 Suppl): 5697S\u20135702S.","journal-title":"Cancer Res"},{"key":"BF2404958_CR11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","volume":"89","author":"K Tsukasaki","year":"1997","unstructured":"Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T et al. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood 1997; 89: 948\u2013956.","journal-title":"Blood"},{"key":"BF2404958_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","volume":"5","author":"A Bazarbachi","year":"2004","unstructured":"Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de The H, El-Sabban ME et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5: 664\u2013672.","journal-title":"Lancet Oncol"},{"key":"BF2404958_CR13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood.V72.5.1805.1805","volume":"72","author":"TA Waldmann","year":"1988","unstructured":"Waldmann TA, Goldman CK, Bongiovanni KF, Sharrow SO, Davey MP, Cease KB et al. Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood 1988; 72: 1805\u20131816.","journal-title":"Blood"},{"key":"BF2404958_CR14","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","volume":"86","author":"TA Waldmann","year":"1995","unstructured":"Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA et al. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood 1995; 86: 4063\u20134075.","journal-title":"Blood"},{"key":"BF2404958_CR15","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","volume":"163","author":"N Azimi","year":"1999","unstructured":"Azimi N, Jacobson S, Leist T, Waldmann TA . Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor. J Immunol 1999; 163: 4064\u20134072.","journal-title":"J Immunol"},{"key":"BF2404958_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1182\/blood-2002-11-3601","volume":"102","author":"Z Zhang","year":"2003","unstructured":"Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA . Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. Blood 2003; 102: 284\u2013288.","journal-title":"Blood"},{"key":"BF2404958_CR17","first-page":"6453","volume":"63","author":"Z Zhang","year":"2003","unstructured":"Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA . Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer Res 2003; 63: 6453\u20136457.","journal-title":"Cancer Res"},{"key":"BF2404958_CR18","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M . Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene 2005; 24: 6047\u20136057.","journal-title":"Oncogene"},{"key":"BF2404958_CR19","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","volume":"103","author":"IC Moura","year":"2004","unstructured":"Moura IC, Lepelletier Y, Arnulf B, England P, Baude C, Beaumont C et al. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 2004; 103: 1838\u20131845.","journal-title":"Blood"},{"key":"BF2404958_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-4157(96)00014-7","volume":"1331","author":"DR Richardson","year":"1997","unstructured":"Richardson DR, Ponka P . The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997; 1331: 1\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"BF2404958_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","volume":"31","author":"P Ponka","year":"1999","unstructured":"Ponka P, Lok CN . The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999; 31: 1111\u20131137.","journal-title":"Int J Biochem Cell Biol"},{"key":"BF2404958_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/07357908609017524","volume":"4","author":"LM Neckers","year":"1986","unstructured":"Neckers LM, Trepel JB . Transferrin receptor expression and the control of cell growth. Cancer Invest 1986; 4: 461\u2013470.","journal-title":"Cancer Invest"},{"key":"BF2404958_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1073\/pnas.80.8.2263","volume":"80","author":"RD Klausner","year":"1983","unstructured":"Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR . Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 1983; 80: 2263\u20132266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404958_CR24","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1073\/pnas.79.20.6186","volume":"79","author":"J van Renswoude","year":"1982","unstructured":"van Renswoude J, Bridges KR, Harford JB, Klausner RD . Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci USA 1982; 79: 6186\u20136190.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404958_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1306.001","volume":"1012","author":"K Pantopoulos","year":"2004","unstructured":"Pantopoulos K . Iron metabolism and the IRE\/IRP regulatory system: an update. Ann NY Acad Sci 2004; 1012: 1\u201313.","journal-title":"Ann NY Acad Sci"},{"key":"BF2404958_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/jcp.36.5.539","volume":"36","author":"KC Gatter","year":"1983","unstructured":"Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY . Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983; 36: 539\u2013545.","journal-title":"J Clin Pathol"},{"key":"BF2404958_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(80)90440-7","volume":"2","author":"WP Faulk","year":"1980","unstructured":"Faulk WP, Hsi BL, Stevens PJ . Transferrin and transferrin receptors in carcinoma of the breast. Lancet 1980; 2: 390\u2013392.","journal-title":"Lancet"},{"key":"BF2404958_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(83)92191-8","volume":"1","author":"JA Habeshaw","year":"1983","unstructured":"Habeshaw JA, Lister TA, Stansfeld AG, Greaves MF . Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet 1983; 1: 498\u2013501.","journal-title":"Lancet"},{"key":"BF2404958_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V60.3.703.703","volume":"60","author":"C Sieff","year":"1982","unstructured":"Sieff C, Bicknell D, Caine G, Robinson J, Lam G, Greaves MF . Changes in cell surface antigen expression during hemopoietic differentiation. Blood 1982; 60: 703\u2013713.","journal-title":"Blood"},{"key":"BF2404958_CR30","first-page":"360","volume":"18","author":"R Taetle","year":"1990","unstructured":"Taetle R . The role of transferrin receptors in hemopoietic cell growth. Exp Hematol 1990; 18: 360\u2013365.","journal-title":"Exp Hematol"},{"key":"BF2404958_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1423-0410.1984.tb00078.x","volume":"46","author":"CJ Yeh","year":"1984","unstructured":"Yeh CJ, Taylor CG, Faulk WP . Transferrin binding by peripheral blood mononuclear cells in human lymphomas, myelomas and leukemias. Vox Sang 1984; 46: 217\u2013223.","journal-title":"Vox Sang"},{"key":"BF2404958_CR32","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1074\/jbc.M908846199","volume":"275","author":"H Kawabata","year":"2000","unstructured":"Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP . Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 2000; 275: 16618\u201316625.","journal-title":"J Biol Chem"},{"key":"BF2404958_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1357-2725(02)00258-3","volume":"35","author":"D Trinder","year":"2003","unstructured":"Trinder D, Baker E . Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 2003; 35: 292\u2013296.","journal-title":"Int J Biochem Cell Biol"},{"key":"BF2404958_CR34","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1182\/blood.V98.9.2714","volume":"98","author":"H Kawabata","year":"2001","unstructured":"Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP . Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 2001; 98: 2714\u20132719.","journal-title":"Blood"},{"key":"BF2404958_CR35","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1182\/blood-2004-06-2481","volume":"104","author":"A Robb","year":"2004","unstructured":"Robb A, Wessling-Resnick M . Regulation of transferrin receptor 2 protein levels by transferrin. Blood 2004; 104: 4294\u20134299.","journal-title":"Blood"},{"key":"BF2404958_CR36","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1182\/blood-2002-01-0076","volume":"100","author":"S Deaglio","year":"2002","unstructured":"Deaglio S, Capobianco A, Cali A, Bellora F, Alberti F, Righi L et al. Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. Blood 2002; 100: 3782\u20133789.","journal-title":"Blood"},{"issue":"Part 3","key":"BF2404958_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/BJ20040230","volume":"381","author":"A Calzolari","year":"2004","unstructured":"Calzolari A, Deaglio S, Sposi NM, Petrucci E, Morsilli O, Gabbianelli M et al. Transferrin receptor 2 protein is not expressed in normal erythroid cells. Biochem J 2004; 381 (Part 3): 629\u2013634.","journal-title":"Biochem J"},{"key":"BF2404958_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bcmd.2007.02.003","volume":"39","author":"A Calzolari","year":"2007","unstructured":"Calzolari A, Oliviero I, Deaglio S, Mariani G, Biffoni M, Sposi NM et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis 2007; 39: 82\u201391.","journal-title":"Blood Cells Mol Dis"},{"key":"BF2404958_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jcp.1041120314","volume":"112","author":"IS Trowbridge","year":"1982","unstructured":"Trowbridge IS, Lesley J, Schulte R . Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody. J Cell Physiol 1982; 112: 403\u2013410.","journal-title":"J Cell Physiol"},{"key":"BF2404958_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000419352","volume":"58","author":"IS Trowbridge","year":"1991","unstructured":"Trowbridge IS, Collawn J, Jing S, White S, Esekogwu V, Stangel M . Structure-function analysis of the human transferrin receptor: effects of anti-receptor monoclonal antibodies on tumor growth. Curr Stud Hematol Blood Transfus 1991; 58: 139\u2013147.","journal-title":"Curr Stud Hematol Blood Transfus"},{"key":"BF2404958_CR41","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1128\/MCB.5.8.1814","volume":"5","author":"JF Lesley","year":"1985","unstructured":"Lesley JF, Schulte RJ . Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies. Mol Cell Biol 1985; 5: 1814\u20131821.","journal-title":"Mol Cell Biol"},{"key":"BF2404958_CR42","first-page":"3817","volume":"55","author":"JD Kemp","year":"1995","unstructured":"Kemp JD, Cardillo T, Stewart BC, Kehrberg E, Weiner G, Hedlund B et al. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor. Cancer Res 1995; 55: 3817\u20133824.","journal-title":"Cancer Res"},{"key":"BF2404958_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ijc.2910320314","volume":"32","author":"R Taetle","year":"1983","unstructured":"Taetle R, Honeysett JM, Trowbridge I . Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells. Int J Cancer 1983; 32: 343\u2013349.","journal-title":"Int J Cancer"},{"issue":"24 Part 1","key":"BF2404958_CR44","first-page":"6989","volume":"49","author":"M Petrini","year":"1989","unstructured":"Petrini M, Pelosi-Testa E, Sposi NM, Mastroberardino G, Camagna A, Bottero L et al. Constitutive expression and abnormal glycosylation of transferrin receptor in acute T-cell leukemia. Cancer Res 1989; 49 (24 Part 1): 6989\u20136996.","journal-title":"Cancer Res"},{"key":"BF2404958_CR45","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1073\/pnas.78.5.3039","volume":"78","author":"IS Trowbridge","year":"1981","unstructured":"Trowbridge IS, Omary MB . Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 1981; 78: 3039\u20133043.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4 Part 1","key":"BF2404958_CR46","first-page":"1759","volume":"46","author":"R Taetle","year":"1986","unstructured":"Taetle R, Castagnola J, Mendelsohn J . Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res 1986; 46 (4 Part 1): 1759\u20131763.","journal-title":"Cancer Res"},{"key":"BF2404958_CR47","first-page":"1259","volume":"1","author":"D Brooks","year":"1995","unstructured":"Brooks D, Taylor C, Dos Santos B, Linden H, Houghton A, Hecht TT et al. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42\/6. Clin Cancer Res 1995; 1: 1259\u20131265.","journal-title":"Clin Cancer Res"},{"key":"BF2404958_CR48","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nbt0905-1073","volume":"23","author":"JM Reichert","year":"2005","unstructured":"Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC . Monoclonal antibody successes in the clinic. Nat Biotechnol 2005; 23: 1073\u20131078.","journal-title":"Nat Biotechnol"},{"key":"BF2404958_CR49","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00262-005-0105-7","volume":"55","author":"Y Qing","year":"2006","unstructured":"Qing Y, Shuo W, Zhihua W, Huifen Z, Ping L, Lijiang L et al. The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor. Cancer Immunol Immunother 2006; 55: 1111\u20131121.","journal-title":"Cancer Immunol Immunother"},{"key":"BF2404958_CR50","doi-asserted-by":"publisher","first-page":"10706","DOI":"10.1073\/pnas.162362999","volume":"99","author":"PP Ng","year":"2002","unstructured":"Ng PP, Dela Cruz JS, Sorour DN, Stinebaugh JM, Shin SU, Shin DS et al. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc Natl Acad Sci USA 2002; 99: 10706\u201310711.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404958_CR51","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2006-04-020263","volume":"108","author":"PP Ng","year":"2006","unstructured":"Ng PP, Helguera G, Daniels TR, Lomas SZ, Rodriguez JA, Schiller G et al. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood 2006; 108: 2745\u20132754.","journal-title":"Blood"},{"key":"BF2404958_CR52","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.194.4.417","volume":"194","author":"IC Moura","year":"2001","unstructured":"Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417\u2013425.","journal-title":"J Exp Med"},{"key":"BF2404958_CR53","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1158\/0008-5472.CAN-06-1962","volume":"67","author":"Y Lepelletier","year":"2007","unstructured":"Lepelletier Y, Camara-Clayette V, Jin H, Hermant A, Coulon S, Dussiot M et al. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments. Cancer Res 2007; 67: 1145\u20131154.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404958","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T07:32:39Z","timestamp":1684049559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BF2404958"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404958","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,27]]},"assertion":[{"value":"13 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}